Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -2.49% is 149% below its 5-year average of 5.06%, near the low end of its 5-year range (-7.69%–16.95%).
22.91% above its 12-month average of -3.23%.
Reported quarterly operating margin; no daily interpolation. Q4 FY2026 (2026-05-31): 1.38%.
OPERATING MARGIN
-2.49%
OPERATING MARGIN AVG TTM
-3.23%
OPERATING MARGIN AVG 3Y
2.89%
OPERATING MARGIN AVG 5Y
5.06%
OPERATING MARGIN AVG 10Y
10.80%
OPERATING MARGIN AVG 15Y
13.68%
OPERATING MARGIN AVG 20Y
16.51%
CURRENT VS TTM AVG
+22.91%
CURRENT VS 3Y AVG
-186.27%
CURRENT VS 5Y AVG
-149.24%
CURRENT VS 10Y AVG
-123.05%
CURRENT VS 15Y AVG
-118.21%
CURRENT VS 20Y AVG
-115.09%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Neogen Corporation
Market Cap
$2.62B
Operating Margin
-2.49%
TTM Avg
-3.23%
3Y Avg
2.89%
5Y Avg
5.06%
Market Cap
$2.58B
Operating Margin
-274.57%
TTM Avg
-464.41%
3Y Avg
-382.79%
5Y Avg
-92575.80%
Market Cap
$2.57B
Operating Margin
1.90%
TTM Avg
1.29%
3Y Avg
0.61%
5Y Avg
-2.83%
Market Cap
$2.65B
Operating Margin
11.12%
TTM Avg
10.91%
3Y Avg
6.08%
5Y Avg
-3.97%
Market Cap
$2.65B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.68B
Operating Margin
10.06%
TTM Avg
14.13%
3Y Avg
15.87%
5Y Avg
13.57%
Market Cap
$2.51B
Operating Margin
-1002.90%
TTM Avg
-694.90%
3Y Avg
-672.96%
5Y Avg
-448.64%
Market Cap
$2.70B
Operating Margin
-1100.78%
TTM Avg
-2270.51%
3Y Avg
-1606.24%
5Y Avg
-1223.21%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Neogen Corporation (NEOG) | $2.62B | -2.49% | -3.23% | 2.89% | 5.06% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.58B | -274.57% | -464.41% | -382.79% | -92575.80% |
| Privia Health Group, Inc. (PRVA)vs › | $2.57B | 1.90% | 1.29% | 0.61% | -2.83% |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.65B | 11.12% | 10.91% | 6.08% | -3.97% |
| MBX Biosciences, Inc. Common Stock (MBX)vs › | $2.65B | 0.00% | 0.00% | 0.00% | 0.00% |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.68B | 10.06% | 14.13% | 15.87% | 13.57% |
| NewAmsterdam Pharma Company N.V. (NAMS)vs › | $2.51B | -1002.90% | -694.90% | -672.96% | -448.64% |
| Precigen, Inc. (PGEN)vs › | $2.70B | -1100.78% | -2270.51% | -1606.24% | -1223.21% |
| AtriCure, Inc. (ATRC)vs › | $2.74B | 2.44% | -4.62% | -7.21% | -5.02% |
| Supernus Pharmaceuticals, Inc. (SUPN)vs › | $2.47B | -5.13% | 3.60% | 3.31% | 10.24% |
Gross Margin
46.9%
Operating Margin
-2.5%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-05-31 | 1.38% |
| 2026-02-28 | -1.56% |
| 2025-11-30 | -2.39% |
| 2025-08-31 | -7.69% |
| 2025-05-31 | -5.88% |
| 2025-02-28 | 5.42% |
| 2024-11-30 | 7.38% |
| 2024-08-31 | 3.99% |
| 2024-05-31 | 7.42% |
| 2024-02-29 | 5.11% |
| 2023-11-30 | 6.30% |
| 2023-08-31 | 8.36% |
| 2023-05-31 | 9.69% |
| 2023-02-28 | 7.19% |
| 2022-11-30 | -3.33% |
| 2022-08-31 | 4.58% |
| 2022-05-31 | 12.87% |
| 2022-02-28 | 4.97% |
| 2021-11-30 | 9.55% |
| 2021-08-31 | 16.95% |
| 2021-05-31 | 15.90% |
| 2021-02-28 | 13.52% |
| 2020-11-30 | 16.73% |
| 2020-08-31 | 17.28% |
| 2020-05-31 | 18.28% |
| 2020-02-29 | 13.06% |
| 2019-11-30 | 16.95% |
| 2019-08-31 | 16.04% |
| 2019-05-31 | 17.06% |
| 2019-02-28 | 14.98% |
| 2018-11-30 | 17.04% |
| 2018-08-31 | 16.54% |
| 2018-05-31 | 18.17% |
| 2018-02-28 | 16.77% |
| 2017-11-30 | 17.87% |
| 2017-08-31 | 17.43% |
| 2017-05-31 | 19.22% |
| 2017-02-28 | 16.24% |
| 2016-11-30 | 18.58% |
| 2016-08-31 | 17.62% |
| 2016-05-31 | 17.35% |
| 2016-02-29 | 14.67% |
| 2015-11-30 | 18.35% |
| 2015-08-31 | 19.90% |
| 2015-05-31 | 18.60% |
| 2015-02-28 | 17.78% |
| 2014-11-30 | 18.84% |
| 2014-08-31 | 19.88% |
| 2014-05-31 | 16.34% |
| 2014-02-28 | 16.60% |
| 2013-11-30 | 16.26% |
| 2013-08-31 | 21.21% |
| 2013-05-31 | 18.27% |
| 2013-02-28 | 18.93% |
| 2012-11-30 | 20.65% |
| 2012-08-31 | 20.77% |
| 2012-05-31 | 17.92% |
| 2012-02-29 | 16.81% |
| 2011-11-30 | 18.14% |
| 2011-08-31 | 20.46% |
| 2011-05-31 | 19.60% |
| 2011-02-28 | 19.10% |
| 2010-11-30 | 21.92% |
| 2010-08-31 | 22.36% |
| 2010-05-31 | 17.81% |
| 2010-02-28 | 16.99% |
| 2009-11-30 | 20.50% |
| 2009-08-31 | 21.47% |
| 2009-05-31 | 17.49% |
| 2009-02-28 | 12.83% |
| 2008-11-30 | 18.79% |
| 2008-08-31 | 19.63% |
| 2008-05-31 | 17.31% |
| 2008-02-29 | 15.81% |
| 2007-11-30 | 17.63% |
| 2007-08-31 | 19.85% |
| 2007-05-31 | 14.15% |
| 2007-02-28 | 14.35% |
| 2006-11-30 | 16.66% |
| 2006-08-31 | 17.70% |
| 2006-05-31 | 15.82% |
| 2006-02-28 | 13.98% |
| 2005-11-30 | 18.33% |
| 2005-08-31 | 18.51% |
| 2005-05-31 | 13.62% |
| 2005-02-28 | 12.34% |
| 2004-11-30 | 13.90% |
| 2004-08-31 | 15.97% |
| 2004-05-31 | 10.61% |
| 2004-02-29 | 11.99% |
| 2003-11-30 | 17.21% |
| 2003-08-31 | 15.32% |
| 2003-05-31 | 14.69% |
| 2003-02-28 | 12.75% |
| 2002-11-30 | 16.59% |
| 2002-08-31 | 14.12% |
